4//SEC Filing
Lo Andrew 4
Accession 0001470831-25-000357
CIK 0001743881other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 5:08 PM ET
Size
537.6 KB
Accession
0001470831-25-000357
Insider Transaction Report
Form 4
Lo Andrew
Director
Transactions
- Sale
Common Stock
2025-11-17$67.06/sh−3,798$254,679→ 14,089 total - Sale
Common Stock
2025-11-18$66.05/sh−30,993$2,047,057→ 50,583 total(indirect: By Andrew W. Lo and Nancy N. Lo JTWROS) - Sale
Common Stock
2025-11-17$66.63/sh−36,801$2,451,914→ 17,887 total - Sale
Common Stock
2025-11-18$65.23/sh−24,007$1,566,013→ 81,576 total(indirect: By Andrew W. Lo and Nancy N. Lo JTWROS)
Footnotes (4)
- [F1]Represents the weighted average sale price of the shares sold from $65.975 to $66.97 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F2]Represents the weighted average sale price of the shares sold from $66.975 to $67.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F3]Represents the weighted average sale price of the shares sold from $64.58 to $65.56 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F4]Represents the weighted average sale price of the shares sold from $65.58 to $66.52 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001679076
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 5:08 PM ET
- Size
- 537.6 KB